本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tyra Biosciences, Inc.

25.43
+0.36001.44%
盤前26.000.5700+2.24%09:05 EDT
成交量:114.23萬
成交額:2,891.18萬
市值:15.13億
市盈率:-10.58
高:25.78
開:24.71
低:24.15
收:25.07
52周最高:40.65
52周最低:12.10
股本:5,948.52萬
流通股本:4,061.85萬
量比:0.43
換手率:2.81%
股息:- -
股息率:- -
每股收益(TTM):-2.4031
每股收益(LYR):-2.0125
淨資產收益率:-45.31%
總資產收益率:-28.46%
市淨率:4.28
市盈率(LYR):-12.64

資料載入中...

2026/09/15

重要事件披露

Form 8-K - Current report
2026/09/14

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/09/09

重要事件披露

Form 8-K - Current report
2026/08/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/07/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/03

重要事件披露

Form 8-K - Current report
2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/12

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/24

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/17

重要事件披露

Form 8-K - Current report